Get the Stockscreener App
2.24
2.75%
0.06
After Hours:
2.28
0.04
+1.79%
Sonoma Pharmaceuticals Inc stock is traded at $2.24, with a volume of 11,979.
It is up +2.75% in the last 24 hours and down -8.76% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$2.18
Open:
$2.19
24h Volume:
11,979
Relative Volume:
0.52
Market Cap:
$3.88M
Revenue:
$17.72M
Net Income/Loss:
$-3.37M
P/E Ratio:
-1.0991
EPS:
-2.038
Net Cash Flow:
$-3.72M
1W Performance:
-2.18%
1M Performance:
-8.76%
6M Performance:
-44.28%
1Y Performance:
-13.85%
1-Day Range:
$2.18
$2.32
1-Week Range:
$2.17
$2.60
52-Week Range:
$2.00
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.24 | 3.77M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
17.85 | 56.39B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
120.76 | 50.93B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.66 | 43.19B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.61 | 36.99B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
577.58 | 25.36B | 3.18B | 1.33B | 1.04B | 27.90 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Will Sonoma Pharmaceuticals Inc stock go up in YEARQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
US Stocks Recap: Can Sonoma Pharmaceuticals Inc expand into new marketsWeekly Trade Report & Safe Capital Growth Tips - baoquankhu1.vn
3 Biotech Stocks Surge with Momentum - National Today
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals Enters U.S. Manufacturing and Supply Pact With Kenvue for Microcyn Line - TradingView — Track All Markets
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
Breakout Move: Is Sonoma Pharmaceuticals Inc currently under institutional pressure2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Opening: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - The Patriot Ledger
Sonoma Pharmaceuticals (SNOA) jumps 16% after hours on burn relief hydrogel launch in Walmart, CVS - msn.com
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS - Benzinga
Market Wrap: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Published on: 2026-03-26 16:02:54 - baoquankhu1.vn
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in Walmart and CVS Stores Nationwide - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - gurufocus.com
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart - Bitget
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart - Investing.com
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart By Investing.com - Investing.com UK
Pharma News: What is Sonoma Pharmaceuticals Incs revenue forecastQuarterly Risk Review & Real-Time Stock Price Movement Reports - baoquankhu1.vn
SNOA Technical Analysis & Stock Price Forecast - Intellectia AI
Sonoma Pharmaceuticals launches Aquanil AD product line By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals launches Aquanil AD - TipRanks
Sonoma Pharmaceuticals launches Aquanil AD product line - Investing.com
Sonoma Pharmaceuticals (SNOA) Launches New Aquanil AD Product Li - gurufocus.com
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquan - PharmiWeb.com
Fierce Biotech Layoff Tracker 2026: Vistagen trims team 20%; Evotec to lay off 800 - Fierce Biotech
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
Performance Recap: Can Sonoma Pharmaceuticals Inc expand into new markets2026 Historical Comparison & Accurate Buy Signal Notifications - baoquankhu1.vn
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):